New Methods, Funding Propel Neurogenetics Closer to Practice

“We are reaching the critical mass level” in neurogenetic research, Dr. Groft said. As increasing numbers of patients with genetic disorders are followed, clinicians and researchers are developing the clinical skills and diagnostic tools to advance the understanding of disease pathogenesis. At the same time, these accomplishments are piquing interest and collaboration from others in the medical community, spurred by the increasing availability of funds and non-monetary support from the government, private foundations, industry, and patient advocacy groups. It is anticipated that neurogenetics is on the cusp of major breakthroughs for clinical neurology.

Disclosures: None of the sources contacted for this article had any relevant financial disclosures.